Platelet-leukocyte interactions: platelets possess an antioxidant armamentarium

• References

• 1 Engelmann B, Luther T, Muller I. Intravascular tissue factor pathway-a model for rapid initiation of coagulation within the blood vessel. Thromb Haemost 2003; 89: 3-8.
• 2 Muller I, Klocke A, Alex M. et al. Intravascular tissue factor initiates coagulation via circulating microvesicles in platelets. FASEB 2003; 17: 476-8.
• 3 Osteoid B. The role of platelets in decrypting monocyte tissue factor. Dis Mon 2003; 49: 7-13.
• 4 Diacovo TG, Roth SG, Buceola JM. et al. Neutrophil rolling, arrest and transmigration across activated, surface-adherent platelets via sequential action of P-selectin and the beta 2-integrin CD11b/CD18. Blood 1996; 88: 146-57.
• 5 Nagata K, Tsuji T, Todoroki N. et al. Activated platelets induce superoxide anion release by monocytes and neutrophils through P-selectin (CD62). J Immunol 1993; 151: 3267-73.
• 6 Colli S, Eligini S, Lalli M. et al. Plateletsneutrophil interaction and superoxide anion generation: involvement of purine nucleotides. Free Radic Biol Med 1996; 20: 271-8.
• 7 Ruf A, Schlenk RF, Maras A. et al. Contactinduced neutrophil activation by platelets in human cell suspension and whole blood. Blood 1992; 80: 1238-46.
• 8 Cadroy Y, Dupouy D, Boneu B. et al. Polymorphonuclear leukocytes modulate tissue factor production by mononuclear cells: role of reactive oxygen species. J Immunol 2000; 164: 3822-8.
• 9 Del Principe D, Menichelli A, De Matteis W. et al. Supernatant from thrombin activated platelets inhibits the polymorphonuclear cell chemiluminescence. In Kricka LJ, Stanley PE, Thorpe GHG TP.. eds Analytical application of Bioluminescence and Chemiluminescence: Academic Press Inc; 1984: 339-42.
• 10 Del Principe D, Menichelli A, Di Giulio S. et al. Stimulated platelets release factor(s) affecting the in vitro response of human polymorphonuclear cells. J Leukoc Biol 1990; 48: 7-14.
• 11 Dallegri F, Ballestrero A, Ottonello L. et al. Platelets as scavengers of neutrophil-derived oxidants: a possible defence mechanism at sites of vascular injury. Thromb Haemost 1989; 61: 415-8.
• 12 Jancinova V, Drabikova K, Nosal R. et al. Platelet-dependent modulation of polymorphonuclear leukocyte chemiluminescence. Platelets 2000; 11: 278-85.
• 13 Losche W, Temmler U, Redlich H. et al. Inhibition of leukocyte chemiluminescence by platelets: role of platelet-bound fibrinogen. Platelets 2001; 12: 15-9.
• 14 Herbertsson H, Bengtsson T. Role of platelets and arachidonic acid pathway in the regulation of neutrophil oxidase activity. Sc and J Clin Lab Invest 2001; 61: 641-9.
• 15 Jancinova V, Rado N, Drabikova K. et al. Cooperation of cloroquine and blood platelets in inhibition of polymorphonuclear leukocyte chemiluminescence. Biochem Pharmacol 2001; 62: 1629-36.
• 16 Spisani S, Giuliani AL, Cavalletti T. et al. Modulation of neutrophil function by activated platelets release factors. Inflammation 1999; 16: 147-58.
• 17 Aziz KA, Cawley JC, Treweeke AT. et al. Sequential potentiation and inhibition of PMN reactivity by maximally stimulated platelets. J Leukoc Biol 1997; 61: 322-8.
• 18 Swain SD, Siemensen DW, Nelson LK. et al. Inhibition of the neutrophil NADPH oxidase by adenosine is associated with increased movement of flavocytocrome b between subcellular fractions. Inflammation 2003; 27: 45-58.
• 19 Brunetti M, Martelli N, Manarini S. et al. Polymorphonuclear leukocyte apoptosis is inhibited by platelet-released mediators, role of TGFbeta-1. Thromb Haemost 2000; 84: 478-83.
• 20 Singh R, Pan S, Mueske CS. et al. Tissue factor pathway inhibitor deficiency enhances neointimal proliferation and formation in a murine model of vascular remodeling. Thromb Haemost 2003; 89: 747-51.
• 21 Kato H. Regulation of functions of vascular wall cells by tissue factor pathway inhibitor. Arterioscler Thromb Vasc Biol 2002; 22: 539-48.
• 22 Bengtsson T, Zalavary S, Stendahl O. et al. Release of oxygen metabolites from chemoattractant-stimulated neutrophils is inhibited by resting platelets: role of extracellular adenosine and actin polymerization. Blood 1996; 15 (87) 4411-23.
• 23 Reinisch CM, Dunzendorfer S, Pechlaner C. et al. The inhibition of oxygen radical release from human neutrophils by resting platelets is reversed by administration of acetylsalicylic acid or Clopidogrel. Free Radie Res 2001; 34: 461-6.